To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
In the US, it is marketed by Bausch and Lomb as Lotemax.
Ocular applications for this drug include the treatment of chronic adenoviral keratitis, Thygeson’s keratitis, vernal keratoconjunctivitis, pingueculitis, and episcleritis. Its use has little or no effect on IOP
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Loteprednol". A list of authors is available in Wikipedia.|